Low level marijuana arrests in New York City rose for the seventh straight year in 2011 to 50,680. The arrest total is the highest total on record since former pot smoker Mayor Michael Bloomberg took office and it is the second highest total of pot arrests ever recorded in the history of the city (just 587 arrests behind the record holding year 2000, when Mayor Rudolph Giuliani oversaw some 51,267 people arrested for marijuana violations).
Shockingly, the near-record high arrest total comes just months after New York City Police Commissioner Ray Kelly called on officers to cease making marijuana misdemeanor arrests. Apparently, NYPD officers aren’t very good at listening to their commanding officer.
Of course, what is most troubling about these arrest figures is that under state law they largely shouldn’t be occurring at all. Since 1977, New York State law has categorized the possession of 25 grams of marijuana or less as a violation, not a misdemeanor crime. So then how are NYPD making so many misdemeanor pot arrests? By violating the spirit of the law, if not the law itself.
Rather than ticketing low level marijuana offenders, City police for over a decade have been taking advantage of a separate statute, NY State Penal Law 221.10, which makes it a criminal misdemeanor to possess pot if it is ‘open to public view.’ According to an investigation last year by New York City public radio station WNYC, it was determined that City cops routinely conduct warrantless ‘stop-and-frisk’ searches of civilians, find marijuana hidden on their persons, and then falsely charge them with possessing pot ‘open to public view.’
And what has been the result of these illegal ‘stop and frisks?’ A press advisory issued yesterday by the Drug Policy Alliance lists the grim details.
– The NYPD has made more than 100,000 marijuana possession arrests for the last two years; nearly 150,000 marijuana possession arrests in the last three years; and more than 227,000 marijuana possession arrests in the last five years.
– New York City spent at least $150 million in the last two years and has spent at least $340 million in the last five years making marijuana possession arrests.
– In the last decade since Michael Bloomberg became mayor, the NYPD has made 400,038 lowest level marijuana possession arrests at a cost to taxpayers of $600 million dollars.
– Nearly 350,000 of the marijuana possession arrests made under Bloomberg are of overwhelmingly young Black and Latino men, despite the fact that young whites use marijuana at higher rates than young Blacks and Latinos.
– In the last five years, the NYPD under Bloomberg has made more marijuana arrests (2007 to 2011 = 227,093) than in the 24 years from 1978 through 2001 under Mayor Giuliani, Mayor Dinkins, and Mayor Koch combined (1978 to 2001 = 226,861).
Commissioner Kelly’s 2011 memorandum explicitly directed officers to stop charging defendants with criminal misdemeanors in instances where the contraband ‘was disclosed to public view at an officer’s direction.’ Nevertheless, the record number of low level pot arrests appears to be continuing unabated. Most likely, it will take an act of law to stop this practice.
Fortunately, bipartisan legislation is pending in both the New York State Assembly and Senate to stop this disgusting, ongoing practice. Assembly Bill 7620 and Senate Bill 5187 reduce marijuana penalties involving cases where where marijuana was either consumed or allegedly possessed in public from a criminal misdemeanor to a non-criminal violation. Passage of SB 5187 and AB 7620 will save taxpayer dollars, protect New York City’s citizens against illegal searches, and reduce unwarranted racial disparities in arrests by clarifying the law and standardizing penalties for marijuana possession offenses.
If you reside in New York and want to end the City’s dubious distinction of being the ‘marijuana arrest capital of the world,’ then please contact your state elected officials today and urge them to support SB 5187 and AB 7620. You can do so via NORML’s ‘Take Action Center’ here.
[Editor's note: This post is excerpted from this week's forthcoming NORML weekly media advisory. To have NORML's news alerts and legislative advisories delivered straight to your in-box, sign up here.]
Some two-thirds of Israeli cancer patients authorized to use cannabis report long-term, symptomatic improvement from the plant, according to clinical data presented in late January at a conference of the Israeli Oncologists Union and reported this week in several international media outlets.
Investigators at the Sheba Medical Center in Tel Aviv, in conjunction with the Israeli Cancer Association, assessed the efficacy of cannabis therapy over the course of one year in 264 patients with cancer. Israeli media reported the findings:
“Some 61 percent of the respondents reported a significant improvement in their quality of life as a result of the medical marijuana, while 56 percent noted an improvement in their ability to manage pain. In general, 67 percent were in favor of the treatment, while 65 percent said they would recommend it to other patients.”
The study concluded that cannabis is an “effective” treatment for certain symptoms of the disease cancer and recommended, “The treatment should be offered to the patients in earlier stages of cancer.”
In the trial, the most common types of cancer for which medical marijuana was authorized was lung cancer (21 percent ), breast cancer (12 percent ) and pancreatic cancer (10 percent ).
The study focused primarily on the use of cannabis to relieve various symptoms of cancer or cancer treatment, such as pain and nausea, but did not evaluate whether marijuana therapy could potentially suppress the proliferation of the disease. In preclinical trials, various cannabinoids – including THC and CBD (cannabidiol) – have been shown to selectively target and eliminate malignant cells and cancerous tumors.
To date, some 6,000 Israelis possess government authorization to use cannabis therapeutically. Patients authorized by the federal program may either cultivate cannabis at home or they may obtain marijuana from one of the nation’s 12 licensed cannabis farms.
Last summer, the Israeli Health Ministry formally acknowledged the therapeutic utility of cannabis and announced newly amended guidelines to more effectively govern the state-sponsored production and distribution of medical marijuana. The Ministry estimates that as many as 40,000 patients will eventually have access to medicinal cannabis once the Israeli program is fully implemented.
NORML’s literature review of the anti-cancer properties of cannabis and cannabinoids is available here.
Last night, President Obama took to Google+ and responded to the questions submitted to him from the general public. Despite accounting for a majority of the top questions, the moderator never asked Obama about marijuana legalization and the president certainly didn’t volunteer any comment of his own volition.
It is immensely disappointing that, yet again, the administration has declined the opportunity to discuss the very serious issue of ending marijuana prohibition in this country. For the ninth time, the White House has solicited the American people for direct input on the issues they cared about, and then, when the resulting answers called overwhelmingly for marijuana law reform, President Obama ignored the will of the American. Over half of the country now supports regulating and taxing marijuana; we can only hope that during the general election the issue is addressed with the respect and urgency it demands. (Alternet)
You can read more details here.
January 2012 marks the beginning of a new legislative session in all 50 states. Already, marijuana law reform legislation is pending (or has been pre-filed) in over a dozen states. To keep up to date with what’s pending, and how you can support marijuana-friendly reform measures in your state, please visit NORML’s ‘Take Action Center’ here.
You can also stay abreast of 2012 statewide ballot initiative efforts, such as those ongoing in Colorado and elsewhere, via NORML’s Legalize 2012 Facebook page here.
Below is this week’s edition of NORML’s Weekly Legislative Round Up — where we spotlight specific examples of pending marijuana law reform legislation from around the country.
** A note to first time readers: NORML can not introduce legislation in your state. Nor can any other non-profit advocacy organization. Only your state representatives, or in some cases an individual constituent (by way of their representative; this is known as introducing legislation ‘by request’) can do so. NORML can — and does — work closely with like-minded politicians and citizens to reform marijuana laws, and lobbies on behalf of these efforts. But ultimately the most effective way — and the only way — to successfully achieve statewide marijuana law reform is for local stakeholders and citizens to become involved in the political process and to make the changes they want to see. Get active; get NORML!
ALABAMA: The Michael Phillips Compassionate Care Act (HB 25) which seeks to enact legal protections for authorized medical marijuana patients, has been marked for reintroduction in the Alabama Legislature for the session starting on February 7th. It is currently assigned to the House Committee on Health. A separate medical cannabis bill, House Bill 66, has also been prefiled in the House and is also before to the House Committee on Health, while a third measure that seeks to reduce penalties on adult cannabis possession is anticipated to be introduced shortly. You can learn more about these efforts via NORML’s ‘Take Action Center’ here.
INDIANA: Senate lawmakers heard testimony on Tuesday, January 24, in favor of legislation, SB 347, to decriminalize marijuana possession penalties in Indiana. Lawmakers on Senate Committee on Corrections, Criminal, and Civil Matters did not vote on the measure. Therefore, there is still time for constituents to contact their Senate members and encourage them to support marijuana law reform. You can do so via NORML’s ‘Take Action Center’ here. A separate House measure, HB 1370, that seeks to legalize the use of cannabis for medicinal purposes, is pending before the House Committee on Public Policy.
KANSAS: House Bill 2330, which seeks to enact legal protections for authorized medical marijuana patients, was heard by the House Committee on Health and Human Services on Tuesday, January 24th. You can read media coverage of the hearing here and here. You can track the progress of this measure and contact your state elected officials regarding HB 2330 here.
NEW HAMPSHIRE: Members of the House Criminal Justice Committee heard testimony on Thursday, January 25, in favor of House Bill 1705, which seeks to allow adults age 21 or over to use marijuana legally in their home. The measure also seeks to establish a regulated cannabis market governing the wholesale production and sale of marijuana. Non-commercial transactions involving less than one ounce of cannabis would not be subject to state taxation or regulation under the measure. You can watch clips from the hearing here and you can contact your elected officials in support of the measure here.
The House Criminal Justice Committee is also scheduled to hear testimony this Thursday in favor of separate legislation, HB 1526, which seeks reduce the penalties on minor marijuana possession offenses (up to one ounce) from a criminal misdemeanor punishable by up to one year in jail and a $2,000 fine to a nominal monetary penalty of no more than $100.00. To contact your House representative regarding HB 1526, please visit NORML’s ‘Take Action Center’ here.
VIRGINIA: Legislation seeking to establish a joint study committee to investigate the fiscal impact of regulating the production and sale of marijuana to adults 21 and over is anticipated to be heard by the Virginia House Committee on Rules as soon as this Thursday. You can read NORML’s published op/eds in support of this measure here and here. To learn more about House Joint Resolution 140, please visit Virginia NORML or contact your state officials here.